header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-170926-2
Fish name: wcm101Tg
Genotype: wcm101Tg
Targeting Reagent: none
HUMAN DISEASE MODELED by wcm101Tg
Human Disease Conditions Citations
thyroid gland carcinoma standard conditions Anelli et al., 2017
GENE EXPRESSION
Gene expression in wcm101Tg
PHENOTYPE
Phenotype in wcm101Tg
Phenotype Conditions Figures
thyroid follicle amount, ameliorated chemical treatment by environment: dabrafenib, chemical treatment by environment: selumetinib Fig. 2 with image from Anelli et al., 2017
thyroid follicle decreased amount, abnormal standard conditions Fig. 1 with imageFig. 2 with image from Anelli et al., 2017
thyroid follicle decreased amount, abnormal chemical treatment by environment: selumetinib Fig. 2 with image from Anelli et al., 2017
thyroid follicle decreased amount, abnormal chemical treatment by environment: dabrafenib Fig. 2 with image from Anelli et al., 2017
thyroid follicle decreased size, abnormal chemical treatment by environment: dabrafenib Fig. 2 with image from Anelli et al., 2017
thyroid follicle decreased size, abnormal chemical treatment by environment: selumetinib Fig. 2 with image from Anelli et al., 2017
thyroid follicle decreased size, abnormal standard conditions Fig. 1 with imageFig. 2 with image from Anelli et al., 2017
thyroid follicle ab9-mapk labeling increased amount, abnormal standard conditions Fig. 4 with imageFig. 5 with image from Anelli et al., 2017
thyroid follicle wnt11r expression increased amount, abnormal control Fig. 3 S1 with image from Anelli et al., 2017
thyroid follicle twist3 expression increased amount, abnormal control Fig. 3 S1 with image from Anelli et al., 2017
thyroid follicle spred2a expression increased amount, abnormal control Fig. 3 S1 with image from Anelli et al., 2017
thyroid follicle her6 expression increased amount, abnormal control Fig. 3 S1 with image from Anelli et al., 2017
thyroid follicle axin2 expression increased amount, abnormal control Fig. 3 S1 with image from Anelli et al., 2017
thyroid follicle fosab expression increased amount, abnormal control Fig. 3 S1 with image from Anelli et al., 2017
thyroid follicle egr1 expression increased amount, abnormal control Fig. 3 S1 with image from Anelli et al., 2017
thyroid follicle morphology, abnormal standard conditions Fig. 1 with imageFig. 7 with image from Anelli et al., 2017
thyroid follicle neoplastic, invasive, abnormal standard conditions Fig. 4 with imageFig. 5 with image from Anelli et al., 2017
thyroid follicle size, ameliorated chemical treatment by environment: dabrafenib, chemical treatment by environment: selumetinib Fig. 2 with image from Anelli et al., 2017
thyroid follicle ab-t4 labeling spatial pattern, abnormal standard conditions Fig. 1 with imageFig. 2 with image from Anelli et al., 2017
thyroid follicle ab-t4 labeling spatial pattern, abnormal chemical treatment by environment: selumetinib Fig. 2 with image from Anelli et al., 2017
thyroid follicle ab-t4 labeling spatial pattern, abnormal chemical treatment by environment: dabrafenib Fig. 2 with image from Anelli et al., 2017
thyroid follicle cell disorganized, abnormal standard conditions Fig. 1 with imageFig. 7 with image from Anelli et al., 2017

CITATIONS  (1)